LATS2 and prostate cancer: Accumulating evidence supports that the LATS family of human tumor suppressors (LATS1 and LATS2) is a new governor of cell homeostasis [38] and LATS2 is downregulated in many cancers, such as prostate cancer [39] and colon cancer [40].